taqpath-covid-19-flu-950x300

Respiratory virus season in the northern hemisphere is rapidly approaching, and this year it will overlap with the ongoing SARS-CoV-2 crisis. It will be important to have a single assay that can detect RNA from different respiratory viruses. Thermo Fisher Scientific is developing solutions to meet this need.

To receive more information about our multiplex real-time PCR solutions for simultaneously detecting RNA from SARS-CoV-2, Flu A, and Flu B (in development) or for simultaneously detecting RNA from SARS-CoV-2, Flu A/B, and RSV (in development), please complete the form below and a sales representative will contact you as soon as possible.

* Required field

*
*
*
*
*
*
*

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 
 

These products are only available to clinical laboratories conducting testing for COVID-19. Regulations prohibit us from providing this product to individual customers.

The real-time PCR kit for SARS-CoV-2, Flu A, Flu B and the real-time PCR kit for SARS-CoV-2, Flu A/B, and RSV described on this webpage have not been CE marked, or authorized by the US FDA or global health agencies, Consult the User’s Manual for information on authorized indication, warnings, and precautions. Once approved: Testing described on this webpage will be designed and intended (i) for use by qualified and trained clinical laboratory personnel specifically instructed and trained in the techniques of real-time PCR and in vitro diagnostic procedures (ii) for use under the Food and Drug Administration’s Emergency Use Authorization. Testing is limited to laboratories that are certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C. 263a, to perform high-complexity tests.

The content provided herein may relate to products or workflows that have not been officially released or fully validated and is subject to change without notice.